Gemcitabine in long infusion and cisplatin for advanced non-small cell lung cancer

被引：0
|
作者：
Segedin, B [1 ]
Zwitter, M [1 ]
Kovac, V [1 ]
Smrdel, U [1 ]
Kocijancic, I [1 ]
机构：
[1] Inst Oncol, Ljubljana, Slovenia
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)81064-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S268 / S269
页数：2
相关论文
共 50 条
  • [1] Gemcitabine and cisplatin for advanced non-small cell lung cancer (NSCLC)
    Casal, J
    Grande, C
    Caeiro, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1083 - 1083
  • [2] Decreased myelotoxicity of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) with cisplatin infusion on day 15
    Cortesi, E
    Ramponi, S
    Corona, M
    Moscetti, L
    Grifalchi, F
    Oliva, A
    Lembo, A
    Gasperoni, S
    Padovani, A
    [J]. LUNG CANCER, 2001, 31 (2-3) : 271 - 276
  • [3] Gemcitabine/vinorelbine/cisplatin in patients with advanced non-small cell lung cancer
    Doweik, L
    Pohl, G
    Malayeri, R
    Krajnik, G
    Minar, W
    Pirker, R
    [J]. 8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 263 - 266
  • [4] Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer
    C H Yang
    C M Tsai
    L S Wang
    Y C Lee
    C J Chang
    L T Lui
    S H Yen
    C Hsu
    A L Cheng
    M Y Liu
    S C Chiang
    Y M Chen
    K T Luh
    M H Huang
    P-C Yang
    R-P Perng
    [J]. British Journal of Cancer, 2002, 86 : 190 - 195
  • [5] A novel biweekly schedule with cisplatin and gemcitabine in advanced non-small cell lung cancer
    López-Vivanco, G
    Fuente, N
    Barceló, R
    Rubio, I
    Muñoz, A
    Mañé, JM
    Pérez-Hoyos, T
    Viteri, A
    Ferreiro, J
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2003, 23 (01) : 9 - 16
  • [6] Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer
    Hasturk, S
    Hatabay, N
    Ece, F
    Karatas, M
    Hanta, I
    [J]. LUNG CANCER, 2005, 49 : S247 - S247
  • [7] Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer
    Yang, CH
    Tsai, CM
    Wang, LS
    Lee, YC
    Chang, CJ
    Lui, LT
    Yen, SH
    Hsu, C
    Cheng, AL
    Liu, MY
    Chiang, SC
    Chen, YM
    Luh, KT
    Huang, MH
    Yang, PC
    Perng, RP
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (02) : 190 - 195
  • [8] Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer
    J. R. Kroep
    E. F. Smit
    G. Giaccone
    K. Van der Born
    J. H. Beijnen
    C. J. Van Groeningen
    W. J. F. Van der Vijgh
    P. E. Postmus
    H. M. Pinedo
    G. J. Peters
    [J]. Cancer Chemotherapy and Pharmacology, 2006, 58 : 509 - 516
  • [9] Gemcitabine and cisplatin in advanced non small cell lung cancer (NSCLC)
    Garcia-Gomez, R
    Lopez-Criado, P
    Guevara, S
    Lahoz, C
    Chaib, C
    Gonzalez, C
    Santiago, J
    De Alvaro, J
    Carrion, R
    Perez-Manga, G
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 93 - 94
  • [10] Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer
    Chen, YM
    Perng, RP
    Whang-Peng, J
    Wu, HW
    Lin, WC
    Tsai, CM
    [J]. LUNG CANCER, 2000, 30 (03) : 199 - 202
12345